ORPHA:91492
Early onset non-syndromic cataract
Publications
12,211
Trials
0
Interventional, condition-specific
Researchers
0
Distinct authors in sample
Gene link
BFSP2, CRYBB3, EPHA2
Moderate
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, non-syndromic developmental defect of the eye disorder, with high clinical and genetic heterogeneity, most frequently characterized by bilateral, symmetrical, non- cataracts which present at birth or in early-childhood. Additional ocular manifestations (e.g. anterior segment dysgenesis, colobomas, nystagmus, microcornea, microphthalmia, myopia) may be associated, however other organs/systems are usually not affected.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0011060
- OMIM:601371
- UMLS:C1832423
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Moderate — BFSP2, CRYBB3, EPHA2
- LiteraturePresent
12,211 matched papers (8,271 in last 10 years) Source
- Phenotype characterisedPresent
119 HPO annotations (e.g. Progressive visual loss; Nuclear cataract; Sutural cataract) Source
- Animal modelPresent
32 genotype models (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 1253 for broader category cataract
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Probably — there is moderate evidence for BFSP2, CRYBB3, EPHA2.
GenCC classification: Moderate.
Phenotypes (Monarch / HPO)
119
Associated phenotypes · MONDO:0011060
- Progressive visual loss
- Nuclear cataract
- Sutural cataract
- Microcornea
- Amblyopia
Showing 5 of 119 — open Monarch for the full list.
Animal models (Monarch / Alliance)
32
Model associations linked to this Mondo ID
- CrygsOpj/Crygs+ [background:] involves: 102 * C3H/He * T STOCK·MGI:3584120·Mus musculus
- MipCat-Fr/MipCat-Fr [background:] involves: A/J·MGI:2175110·Mus musculus
- CrygbNop/CrygbNop [background:] Not Specified·MGI:2175806·Mus musculus
- Lim2To3/Lim2To3 [background:] involves: 102 * C3H/He * T STOCK·MGI:2175102·Mus musculus
- MipHfi/Mip+ [background:] involves: 101 * C3H·MGI:2175115·Mus musculus
- CrygsOpj/CrygsOpj [background:] involves: 102 * C3H/He * T STOCK·MGI:3584122·Mus musculus
- CrygbClapper/Crygb+ [background:] C57BL/6J-CrygbClapper·MGI:3603148·Mus musculus
- CrygbNop/Crygb+ [background:] Not Specified·MGI:2175807·Mus musculus
- Tg(Hsf4/EGFP)N7Spbh/0 [background:] C57BL/6-Tg(Hsf4/EGFP)N7Spbh·MGI:5810684·Mus musculus
- MipCat-Tohm/MipCat-Tohm [background:] involves: DDI·MGI:2657109·Mus musculus
- Crygsrncat/Crygsrncat [background:] Kunming·MGI:2181684·Mus musculus
- Cryba1Po1/Cryba1Po1 [background:] C3HeB/FeJ-Cryba1Po1·MGI:2175801·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
12,211
12,211 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
12,211 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
8,271 in the last 10 years · low confidence
Phrase hits: 0 · MeSH hits: 0
Who's working on it?
0
Distinct author names in 0 sampled papers.
Who's working on it?
No author names could be extracted from the sampled publications. Try the Europe PMC query in “How we counted this,” or contact an umbrella rare-disease organisation for researcher referrals.
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1,253 trials are registered for cataract, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 26 October 2026 · last trial check 26 October 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5498 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1,253 interventional trials matched cataract, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: cataract
1,253
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07260695·RECRUITING·Odyssey Evaluation in Post LASIK Patients
Conditions: Cataract·Matched via name phrase
- NCT07015034·RECRUITING·Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
Conditions: Vision Impairment and Blindness · Glaucoma · Age-Related Macular Degeneration · Cataract·Matched via name phrase
- NCT06950619·NOT YET RECRUITING·Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features
Conditions: Congenital Cataract · Tooth Abnormalities · Ocular Pathologies·Matched via name phrase
- NCT07325227·NOT YET RECRUITING·Study of Remimazolam for Cataract Surgery
Conditions: Cataract Surgery Anesthesia·Matched via name phrase
- NCT06865235·RECRUITING·Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.
Conditions: Open Angle Glaucoma (OAG)·Matched via name phrase
- NCT06990074·RECRUITING·An Early Feasibility, Prospective, Single-Arm Study of the Polaris System
Conditions: Cataract, Age-Related·Matched via name phrase
- NCT07713069·NOT YET RECRUITING·OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction
Conditions: Cataract·Matched via name phrase
- NCT07587138·RECRUITING·Clinical Evaluation of a Novel Trifocal IOL
Conditions: Aphakia · Cataract·Matched via name phrase
- NCT07418333·NOT YET RECRUITING·Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.
Conditions: Cataract Surgery · Ocular Infections·Matched via name phrase
- NCT07407049·NOT YET RECRUITING·Comparison of Early Postoperative Visual Acuity Between Intracapsular and Supracapsular Phacoemulsification: A Randomized Controlled Clinical Trial
Conditions: Cataract·Matched via name phrase
- NCT07657858·RECRUITING·Effect of Dry Eye Treatment on Corneal Astigmatism Measurements
Conditions: Dry Eye · Cataract·Matched via name phrase
- NCT07790887·NOT YET RECRUITING·A Prospective, Single-Arm Clinical Evaluation of Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of the TECNIS PureSee™ Extended Depth of Focus Intraocular Lens
Conditions: Cataract·Matched via name phrase
- NCT07218796·RECRUITING·Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Conditions: Cataract · Glaucoma · Ocular Hypertension·Matched via name phrase
- NCT07484659·RECRUITING·Reducing Patient Waiting Time for Cataract Surgery
Conditions: Cataract Surgery·Matched via name phrase
- NCT05587205·RECRUITING·Safety and Tolerability of EO2002
Conditions: Cataract · Endothelial Cell Loss, Corneal·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Early onset non-syndromic cataract — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Early onset non-syndromic cataract") OR ("BFSP2" OR "BFSP2 syndrome" OR "BFSP2-related" OR "CRYBB3" OR "CRYBB3 syndrome" OR "CRYBB3-related" OR "EPHA2" OR "EPHA2 syndrome" OR "EPHA2-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Early onset non-syndromic cataract"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"cataract"
Query health: ok — strategies attempted: phrase; with hits: none
Parent literature probe: cataract (MONDO:0005129) — 197446 hits
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (12211) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T04:03:50.385Z
